Literature DB >> 8723815

A 10-year experience in pediatric after-hours telecommunications.

J C Pert1, T W Furth, H P Katz.   

Abstract

A rapidly growing area within the field of telephone medicine is the use of centralized telephone triage systems to help in the after-hours coverage of pediatric practices. This paper describes a 10-year experience with a pediatric telecommunications program within the 302,000-member Health Centers Division of Harvard Pilgrim Health Care. Telephone volume averages 3,000 calls per month, and over 175,000 telephone calls have been received since the program began. This article highlights the linkage to the primary care physician, the enhancement of service by the automated medical record system, and the application of the telecommunications program to resident teaching. The literature review focuses on the rationale for structured telecommunications programs, including improved quality of care, reduction of medicolegal risk, and the potential for reimbursement of services.

Mesh:

Year:  1996        PMID: 8723815     DOI: 10.1097/00008480-199604000-00018

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  Telephone medicine for internists.

Authors:  D M Elnicki; P Ogden; M Flannery; M Hannis; S Cykert
Journal:  J Gen Intern Med       Date:  2000-05       Impact factor: 5.128

2.  After-hours paediatric telephone triage and advice: the Neuchâtel experience.

Authors:  Sybil Bolli; Guy Van Melle; Bernard Laubscher
Journal:  Eur J Pediatr       Date:  2005-05-19       Impact factor: 3.183

3.  Patient safety and telephone medicine : some lessons from closed claim case review.

Authors:  Harvey P Katz; Dawn Kaltsounis; Liz Halloran; Maureen Mondor
Journal:  J Gen Intern Med       Date:  2008-01-29       Impact factor: 5.128

4.  Telemedicine in the pediatric surgery in Germany during the COVID-19 pandemic.

Authors:  G Lakshin; S Banek; D Keese; U Rolle; A Schmedding
Journal:  Pediatr Surg Int       Date:  2021-01-02       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.